These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24863156)

  • 1. Recruitment and screening for a randomized trial investigating Roux-en-Y gastric bypass versus intensive medical management for treatment of type 2 diabetes.
    Thomas AJ; Bainbridge HA; Schone JL; Chen SC; Connett JE; Ikramuddin S; Lee WJ; Jensen MD; Leslie DB; Korner J
    Obes Surg; 2014 Nov; 24(11):1875-80. PubMed ID: 24863156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Differences in Remission of Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass Surgery-Subgroup Analysis of 2-Year Results of the Diabetes Surgery Study Comparing Taiwanese with Americans with Mild Obesity (BMI 30-35 kg/m
    Chong K; Ikramuddin S; Lee WJ; Billington CJ; Bantle JP; Wang Q; Thomas AJ; Connett JE; Leslie DB; Inabnet WB; Jeffery RW; Sarr MG; Jensen MD; Vella A; Ahmed L; Belani K; Schone JL; Olofson AE; Bainbridge HA; Laqua PS; Korner J; Chuang LM
    Obes Surg; 2017 May; 27(5):1189-1195. PubMed ID: 27783367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of Roux-en-Y gastrojejunostomy and LRYGB with small stomach pouch on type 2 diabetes mellitus in patients with BMI<35 kg/m(2).
    Yi B; Jiang J; Zhu L; Li P; Im I; Zhu S
    Surg Obes Relat Dis; 2015; 11(5):1061-8. PubMed ID: 25843397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Roux-en-Y gastric bypass with different pouch size in Chinese T2DM patients with BMI 30-35 kg/m2.
    Ren Y; Yang W; Yang J; Wang C
    Obes Surg; 2015 Mar; 25(3):457-63. PubMed ID: 25236397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Durability of Addition of Roux-en-Y Gastric Bypass to Lifestyle Intervention and Medical Management in Achieving Primary Treatment Goals for Uncontrolled Type 2 Diabetes in Mild to Moderate Obesity: A Randomized Control Trial.
    Ikramuddin S; Korner J; Lee WJ; Bantle JP; Thomas AJ; Connett JE; Leslie DB; Inabnet WB; Wang Q; Jeffery RW; Chong K; Chuang LM; Jensen MD; Vella A; Ahmed L; Belani K; Olofson AE; Bainbridge HA; Billington CJ
    Diabetes Care; 2016 Sep; 39(9):1510-8. PubMed ID: 27311493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized Controlled Trial of One Anastomosis Gastric Bypass Versus Roux-En-Y Gastric Bypass for Obesity: Comparison of the YOMEGA and Taiwan Studies.
    Lee WJ; Almalki OM; Ser KH; Chen JC; Lee YC
    Obes Surg; 2019 Sep; 29(9):3047-3053. PubMed ID: 31290104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roux-en-Y gastric bypass versus best medical treatment for type 2 diabetes mellitus in adults with body mass index between 27 and 32 kg/m
    Cheng A; Yeoh E; Moh A; Low S; Tan CH; Lam B; Sum CF; Subramaniam T; Lim SC
    Diabetes Res Clin Pract; 2022 Jun; 188():109900. PubMed ID: 35513159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early results of Roux-en-Y gastric by-pass on regulation of diabetes type 2 in patients with BMI above and below 35 kg/m2.
    Proczko-Markuszewska M; Stefaniak T; Kaska Ł; Sledziński Z
    Pol Przegl Chir; 2011 Feb; 83(2):81-6. PubMed ID: 22166285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial.
    Ikramuddin S; Billington CJ; Lee WJ; Bantle JP; Thomas AJ; Connett JE; Leslie DB; Inabnet WB; Jeffery RW; Chong K; Chuang LM; Sarr MG; Jensen MD; Vella A; Ahmed L; Belani K; Schone JL; Olofson AE; Bainbridge HA; Laqua PS; Wang Q; Korner J
    Lancet Diabetes Endocrinol; 2015 Jun; 3(6):413-422. PubMed ID: 25979364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of laparoscopic sleeve gastrectomy versus roux-en-Y gastric bypass for the treatment of Chinese type 2 diabetes mellitus patients with body mass index 28-35 kg/m(2).
    Yang J; Wang C; Cao G; Yang W; Yu S; Zhai H; Pan Y
    BMC Surg; 2015 Jul; 15():88. PubMed ID: 26198306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic control and BMI changes after endoscopic implantation of a duodenojejunal bypass liner compared with laparoscopic Roux-en-Y gastric bypass surgery: a propensity score matching analysis.
    Günthert SJ; Aksan A; Schröder O; Meyer G; Hausmann J; Stein J; Stier C
    Surg Endosc; 2022 Aug; 36(8):5979-5985. PubMed ID: 35378626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between type 2 diabetes remission after gastric bypass and different weight loss metrics: arguments against excess weight loss in metabolic surgery.
    van de Laar AW; de Brauw LM; Meesters EW
    Surg Obes Relat Dis; 2016 Feb; 12(2):274-82. PubMed ID: 26476492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgery for weight loss in adults.
    Colquitt JL; Pickett K; Loveman E; Frampton GK
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD003641. PubMed ID: 25105982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study.
    Ikramuddin S; Korner J; Lee WJ; Thomas AJ; Connett JE; Bantle JP; Leslie DB; Wang Q; Inabnet WB; Jeffery RW; Chong K; Chuang LM; Jensen MD; Vella A; Ahmed L; Belani K; Billington CJ
    JAMA; 2018 Jan; 319(3):266-278. PubMed ID: 29340678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Roux-en-Y Gastric Bypass on Remission of T2D: Medium-Term Follow-up in Chinese Patients with Different BMI Obesity Class.
    Zhang H; Han X; Yu H; Di J; Zhang P; Jia W
    Obes Surg; 2017 Jan; 27(1):134-142. PubMed ID: 27312346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for Relapse of Hyperglycemia after Laparoscopic Roux-en-Y Gastric Bypass in T2DM Obese Patients: a 5-Year Follow-Up of 24 Cases.
    Xiaosong W; Chongyu S; Xuqi S; Peiwu Y; Yongliang Z
    Obes Surg; 2019 Apr; 29(4):1164-1168. PubMed ID: 30645722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.
    Halperin F; Ding SA; Simonson DC; Panosian J; Goebel-Fabbri A; Wewalka M; Hamdy O; Abrahamson M; Clancy K; Foster K; Lautz D; Vernon A; Goldfine AB
    JAMA Surg; 2014 Jul; 149(7):716-26. PubMed ID: 24899464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roux-en-Y Gastric Bypass Versus Medical Treatment for Type 2 Diabetes Mellitus in Obese Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Yan Y; Sha Y; Yao G; Wang S; Kong F; Liu H; Zhang G; Zhang H; Hu C; Zhang X
    Medicine (Baltimore); 2016 Apr; 95(17):e3462. PubMed ID: 27124041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes (ARMMS-T2D): Study rationale, design, and methods.
    Simonson DC; Hu B; Arterburn DE; Schauer PR; Kashyap SR; Courcoulas AP; Cummings DE; Patti ME; Gourash WF; Vernon AH; Jakicic JM; Kirwan JP
    Diabetes Obes Metab; 2022 Jul; 24(7):1206-1215. PubMed ID: 35233923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF 19 and Bile Acids Increase Following Roux-en-Y Gastric Bypass but Not After Medical Management in Patients with Type 2 Diabetes.
    Sachdev S; Wang Q; Billington C; Connett J; Ahmed L; Inabnet W; Chua S; Ikramuddin S; Korner J
    Obes Surg; 2016 May; 26(5):957-65. PubMed ID: 26259981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.